MTEP
3-((2-Methyl-4-thiazolyl)ethynyl)pyridine (MTEP) is a research drug that was developed by Merck & Co. as a selective allosteric antagonist of the metabotropic glutamate receptor subtype mGluR5. Identified through structure-activity relationship studies on an older mGluR5 antagonist MPEP, MTEP has subsequently itself acted as a lead compound for newer and even more improved drugs.
Wikipage redirect
primaryTopic
MTEP
3-((2-Methyl-4-thiazolyl)ethynyl)pyridine (MTEP) is a research drug that was developed by Merck & Co. as a selective allosteric antagonist of the metabotropic glutamate receptor subtype mGluR5. Identified through structure-activity relationship studies on an older mGluR5 antagonist MPEP, MTEP has subsequently itself acted as a lead compound for newer and even more improved drugs.
has abstract
3-((2-Methyl-4-thiazolyl)ethyn ...... , cocaine and methamphetamine.
@en
CAS number
329205-68-7
IUPAC name
3-[(2-methyl-1,3-thiazol-4-yl)ethynyl]pyridine
@en
PubChem
thumbnail
Wikipage page ID
20,245,287
Wikipage revision ID
743,076,059
Alt
Skeletal formula
Space-filling model
ChemSpiderID
IUPHAR ligand
molecular weight
smiles
CC1=NCC#CC2=CN=CC=C2
StdInChIKey
NRBNGHCYDWUVLC-UHFFFAOYSA-N
Verifiedfields
verifiedrevid
424,696,647
Watchedfields
hypernym
comment
3-((2-Methyl-4-thiazolyl)ethyn ...... and even more improved drugs.
@en
label
MTEP
@en
